Orchard Therapeutics Total Assets 2017-2019 | ORTX

Orchard Therapeutics total assets from 2017 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Orchard Therapeutics Annual Total Assets
(Millions of US $)
2018 $366
2017 $97
2016 $4
Orchard Therapeutics Quarterly Total Assets
(Millions of US $)
Q2 2019 $458
Q1 2019 $329
Q4 2018 $366
Q2 2018 $65
Q1 2018 $0
Q4 2017 $97
Q4 2016 $4
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.330B $0.002B
Orchard Therapeutics plc is a biopharmaceutical company. It offers medical research, gene therapy and inherited disorder treatment services which transforms the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. Orchard Therapeutics plc is based in London, United Kingdom.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.973B 13.44
Gilead Sciences (GILD) United States $83.801B 10.29
CSL (CSLLY) Australia $73.135B 0.00
Celgene (CELG) United States $69.882B 10.81
Vertex Pharmaceuticals (VRTX) United States $45.238B 48.89
Biogen (BIIB) United States $44.028B 7.82
Illumina (ILMN) United States $43.846B 51.51
Regeneron Pharmaceuticals (REGN) United States $31.645B 14.36
Alexion Pharmaceuticals (ALXN) United States $24.178B 12.75
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $17.012B 50.06
Exact Sciences (EXAS) United States $13.838B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.460B 0.00
Genmab (GNMSF) Denmark $12.400B 69.55
Seattle Genetics (SGEN) United States $11.636B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.952B 53.35
Alnylam Pharmaceuticals (ALNY) United States $9.766B 0.00
Galapagos (GLPG) Belgium $8.741B 0.00
QIAGEN (QGEN) Netherlands $7.697B 25.28
Bio-Techne Corp (TECH) United States $7.490B 51.75
Guardant Health (GH) United States $6.947B 0.00
BeiGene (BGNE) Cayman Islands $6.321B 0.00
Sarepta Therapeutics (SRPT) United States $6.310B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.155B 0.00
Amarin (AMRN) Ireland $6.133B 0.00
Bluebird Bio (BLUE) United States $5.898B 0.00
Exelixis (EXEL) United States $5.867B 15.25
Moderna (MRNA) United States $5.831B 0.00
Horizon Pharma Public (HZNP) Ireland $4.973B 12.64
ARGENX SE-ADR (ARGX) Netherlands $4.915B 0.00
Ascendis Pharma (ASND) Denmark $4.355B 0.00
Repligen (RGEN) United States $4.173B 80.99
China Biologic Products (CBPO) China $4.045B 25.25
Spark Therapeutics (ONCE) United States $4.018B 0.00
Blueprint Medicines (BPMC) United States $3.975B 0.00
Medicines (MDCO) United States $3.784B 0.00
MorphoSys AG (MOR) Germany $3.689B 0.00
Mirati Therapeutics (MRTX) United States $3.467B 0.00
Alkermes (ALKS) Ireland $3.367B 0.00
Immunomedics (IMMU) United States $3.348B 0.00
Emergent Biosolutions (EBS) United States $2.751B 41.33
CRISPR Therapeutics AG (CRSP) Switzerland $2.690B 0.00
Reata Pharmaceuticals (RETA) United States $2.672B 0.00
Genomic Health (GHDX) United States $2.661B 49.91
Arena Pharmaceuticals (ARNA) United States $2.588B 5.56
Ultragenyx Pharmaceutical (RARE) United States $2.551B 0.00
MyoKardia (MYOK) United States $2.508B 0.00
Amicus Therapeutics (FOLD) United States $2.493B 0.00
Halozyme Therapeutics (HALO) United States $2.416B 0.00
Acceleron Pharma (XLRN) United States $2.356B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.287B 0.00
NeoGenomics (NEO) United States $2.227B 119.11
Myriad Genetics (MYGN) United States $2.107B 22.11
Akcea Therapeutics (AKCA) United States $2.059B 0.00
Zai Lab (ZLAB) China $2.028B 0.00
Cambrex (CBM) United States $2.007B 25.37
Ligand Pharmaceuticals (LGND) United States $1.882B 23.79
UniQure (QURE) Netherlands $1.837B 0.00
Denali Therapeutics (DNLI) United States $1.822B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.724B 0.00
Insmed (INSM) United States $1.709B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.564B 0.00
REGENXBIO (RGNX) United States $1.442B 0.00
Coherus BioSciences (CHRS) United States $1.395B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.377B 0.00
Alector (ALEC) United States $1.348B 0.00
Sangamo Therapeutics (SGMO) United States $1.291B 0.00
Editas Medicine (EDIT) United States $1.276B 0.00
AnaptysBio (ANAB) United States $1.210B 0.00
RA PHARMCTL INC (RARX) United States $1.205B 0.00
Innoviva (INVA) United States $1.153B 3.33
Fate Therapeutics (FATE) United States $1.111B 0.00
Athenex (ATNX) United States $1.100B 0.00
Epizyme (EPZM) United States $1.068B 0.00
Zymeworks (ZYME) Canada $1.004B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.979B 0.00
Twist Bioscience (TWST) United States $0.977B 0.00
Cara Therapeutics (CARA) United States $0.950B 0.00
WAVE Life Sciences (WVE) Singapore $0.904B 0.00
ANI Pharmaceuticals (ANIP) United States $0.894B 14.94
BAVARIAN NORDIC (BVNRY) Denmark $0.875B 0.00
Codexis (CDXS) United States $0.852B 0.00
Arvinas (ARVN) United States $0.837B 0.00
Principia Biopharma (PRNB) United States $0.833B 434.38
Cytokineticsorporated (CYTK) United States $0.770B 0.00
Zealand Pharma (ZEAL) Denmark $0.766B 8.88
Anika Therapeutics (ANIK) United States $0.751B 26.58
ZIOPHARM Oncology Inc (ZIOP) United States $0.746B 0.00
Mesoblast (MESO) Australia $0.736B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.726B 26.21
Intellia Therapeutics (NTLA) United States $0.725B 0.00
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Pharming Group (PHGUF) Netherlands $0.706B 0.00
Vericel (VCEL) United States $0.706B 0.00
Revance Therapeutics (RVNC) United States $0.639B 0.00
MiMedx (MDXG) United States $0.586B 0.00
DBV Technologies S.A (DBVT) France $0.576B 0.00
Heska (HSKA) United States $0.546B 70.69
Achillion Pharmaceuticals (ACHN) United States $0.543B 0.00
Cellectis S.A (CLLS) France $0.535B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
Retrophin (RTRX) United States $0.516B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.506B 0.00
Intra-Cellular Therapies (ITCI) United States $0.505B 0.00
Precision BioSciences (DTIL) United States $0.502B 0.00
UROGEN PHARMA (URGN) United States $0.500B 0.00
Syros Pharmaceuticals (SYRS) United States $0.486B 0.00
Stemline Therapeutics (STML) United States $0.476B 0.00
PHARMA MAR SA (PHMMF) Spain $0.468B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Puma Biotechnology (PBYI) United States $0.454B 0.00
Arcus Biosciences (RCUS) United States $0.439B 0.00
BioDelivery Sciences (BDSI) United States $0.423B 0.00
CytomX Therapeutics (CTMX) United States $0.421B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.419B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.417B 0.00
Agenus (AGEN) United States $0.404B 0.00
Adverum Biotechnologies (ADVM) United States $0.400B 0.00
Bellus Health (BLU) Canada $0.384B 0.00
Protagonist Therapeutics (PTGX) United States $0.383B 0.00
Merus (MRUS) Netherlands $0.383B 0.00
AC Immune SA (ACIU) Switzerland $0.361B 26.75
Gritstone Oncology (GRTS) United States $0.354B 0.00
Scholar Rock Holding (SRRK) United States $0.351B 0.00
Prothena (PRTA) Ireland $0.347B 0.00
Kadmon Holdings (KDMN) United States $0.340B 0.00
Avid Bioservices (CDMO) United States $0.328B 0.00
Theratechnologies (THERF) Canada $0.326B 0.00
Albireo Pharma (ALBO) United States $0.323B 0.00
Kindred Biosciences (KIN) United States $0.316B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.312B 0.00
Biofrontera AG (BFRA) Germany $0.312B 466.67
ADMA Biologics Inc (ADMA) United States $0.311B 0.00
Sorrento Therapeutics (SRNE) United States $0.308B 0.00
Pfenex (PFNX) United States $0.304B 0.00
Dynavax Technologies (DVAX) United States $0.304B 0.00
Cel-Sci (CVM) United States $0.300B 0.00
Starpharma Holdings (SPHRY) Australia $0.295B 0.00
Clovis Oncology (CLVS) United States $0.292B 0.00
Cellular Biomedicine (CBMG) United States $0.284B 0.00
Geron (GERN) United States $0.281B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.268B 0.00
MannKind (MNKD) United States $0.262B 0.00
Senesco Technologies (ELOX) United States $0.259B 0.00
Seres Therapeutics (MCRB) United States $0.257B 0.00
PDL BioPharma (PDLI) United States $0.255B 6.56
Aeglea BioTherapeutics (AGLE) United States $0.254B 0.00
Sutro Biopharma (STRO) United States $0.252B 0.00
ChromaDex (CDXC) United States $0.250B 0.00
Inovio Pharmaceuticals (INO) United States $0.249B 0.00
Prometic Life Sciences (PFSCF) Canada $0.242B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.239B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.239B 0.00
Palatin Technologies (PTN) United States $0.232B 6.80
Athersys (ATHX) United States $0.227B 0.00
POXEL SA FRANCE (PXXLF) France $0.227B 0.00
Affimed (AFMD) Germany $0.224B 0.00
Spero Therapeutics (SPRO) United States $0.223B 0.00
Compugen (CGEN) Israel $0.222B 0.00
Cue Biopharma (CUE) United States $0.210B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.209B 0.00
Kamada (KMDA) Israel $0.208B 7.95
EXICURE INC (XCUR) United States $0.204B 0.00
Five Prime Therapeutics (FPRX) United States $0.202B 0.00
CorMedix Inc (CRMD) United States $0.200B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.195B 0.00
OSMOTICA PHARM (OSMT) United States $0.193B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.188B 0.00
XOMA (XOMA) United States $0.177B 0.00
Nicox SA (NICXF) France $0.173B 0.00
Arsanis (XFOR) United States $0.170B 0.00
Enzo Biochem (ENZ) United States $0.170B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.169B 0.00
Dyadic (DYAI) United States $0.165B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Acorda Therapeutics (ACOR) United States $0.163B 0.00
Novavax (NVAX) United States $0.161B 0.00
Alcobra (ARCT) United States $0.156B 0.00
Strongbridge Biopharma (SBBP) United States $0.150B 6.16
BioTime (LCTX) United States $0.150B 10.00
Paratek Pharmaceuticals (PRTK) United States $0.146B 0.00
Cerecor (CERC) United States $0.146B 0.00
Emmaus Life Sciences (EMMA) United States $0.146B 0.00
Northwest Biotherapeutics (NWBO) United States $0.145B 0.00
Abeona Therapeutics (ABEO) United States $0.144B 0.00
Adocia (ADOCY) France $0.140B 0.00
PHASEBIO PHARMA (PHAS) United States $0.136B 0.00
Aptinyx (APTX) United States $0.134B 0.00
NantKwest (NK) United States $0.132B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.131B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Fortress Biotech (FBIO) United States $0.128B 0.00
Menlo Therapeutics (MNLO) United States $0.128B 0.00
SESEN BIO, INC (SESN) United States $0.113B 0.00
Aduro Biotech (ADRO) United States $0.103B 0.00
Verastem (VSTM) United States $0.099B 0.00
Celyad SA (CYAD) Belgium $0.099B 0.00
Checkpoint Therapeutics (CKPT) United States $0.095B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.095B 0.00
Arbutus Biopharma (ABUS) Canada $0.094B 0.00
VTv Therapeutics (VTVT) United States $0.094B 0.00
Trevena (TRVN) United States $0.092B 0.00
OvaScience (MLND) United States $0.091B 0.00
Vaccinex (VCNX) United States $0.088B 0.00
Mersana Therapeutics (MRSN) United States $0.086B 0.00
Idera Pharmaceuticals (IDRA) United States $0.086B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.086B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.083B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Antibe Therapeutics (ATBPF) Canada $0.080B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Liquidia Technologies (LQDA) United States $0.075B 0.00
Catalyst Biosciences (CBIO) United States $0.072B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.072B 0.00
NewLink Genetics (NLNK) United States $0.071B 0.00
VBI Vaccines (VBIV) United States $0.071B 0.00
Orgenesis (ORGS) United States $0.070B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Curis (CRIS) United States $0.069B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 37.80
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
ARAVIVE, INC (ARAV) United States $0.067B 0.00
Pluristem Therapeutics (PSTI) Israel $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.065B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.063B 0.00
Unum Therapeutics (UMRX) United States $0.061B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.059B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
AIT Therapeutics (XAIR) United States $0.052B 0.00
VistaGen Therapeutics (VTGN) United States $0.051B 0.00
Oncobiologics (OTLK) United States $0.048B 0.00
Proteostasis Therapeutics (PTI) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Ophthotech (ISEE) United States $0.046B 0.00
VIVUS (VVUS) United States $0.046B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.043B 0.00
BIOCARDIA INC (BCDA) United States $0.042B 0.00
Evogene (EVGN) Israel $0.042B 0.00
Stellar Biotechnologies (EDSA) Canada $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.033B 0.00
Protalix BioTherapeutics (PLX) Israel $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.029B 0.00
Apricus Biosciences (SEEL) United States $0.029B 0.00
AEterna Zentaris (AEZS) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.77
Clearside Biomedical (CLSD) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.028B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
TOCAGEN INC (TOCA) United States $0.021B 0.00
Soligenix (SNGX) United States $0.019B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
IBio (IBIO) United States $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Benitec Biopharma (BNTC) Australia $0.012B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00